All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Renal Impairment Study for Oral EC5026

Conditions : Chronic Kidney Disease Interventions : Drug: EC5026 oral tablet Sponsors : EicOsis Human Health Inc. Recruiting

Read the full article
16h agoen
sciencehealth

You might also wanna read

Untitled

Telitacicept, a fusion protein targeting BAFF and APRIL, shows promise for IgA nephropathy in a phase 3 trial. Proteinuria ≥1.0 g/day addres

doi.org·23d ago

Comments

Sign in to join the conversation.

No comments yet. Be the first.